In the past week, SRTS stock has gone up by 10.59%, with a monthly decline of -0.79% and a quarterly surge of 13.60%. The volatility ratio for the week is 6.86%, and the volatility levels for the last 30 days are 7.50% for Sensus Healthcare Inc The simple moving average for the past 20 days is 11.92% for SRTS’s stock, with a 24.24% simple moving average for the past 200 days.
Is It Worth Investing in Sensus Healthcare Inc (NASDAQ: SRTS) Right Now?
Sensus Healthcare Inc (NASDAQ: SRTS) has a price-to-earnings ratio of 127.03x that is above its average ratio. Additionally, the 36-month beta value for SRTS is 0.96. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for SRTS is 12.90M and currently, short sellers hold a 0.26% ratio of that float. The average trading volume of SRTS on May 01, 2024 was 145.00K shares.
SRTS) stock’s latest price update
Sensus Healthcare Inc (NASDAQ: SRTS)’s stock price has gone rise by 10.91 in comparison to its previous close of 3.39, however, the company has experienced a 10.59% increase in its stock price over the last five trading days. GlobeNewsWire reported 2024-04-18 that BOCA RATON, Fla., April 18, 2024 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, May 9, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the first quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Analysts’ Opinion of SRTS
Alliance Global Partners gave a rating of “Buy” to SRTS, setting the target price at $4.25 in the report published on August 10th of the previous year.
SRTS Trading at -0.71% from the 50-Day Moving Average
After a stumble in the market that brought SRTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -30.11% of loss for the given period.
Volatility was left at 7.50%, however, over the last 30 days, the volatility rate increased by 6.86%, as shares surge +8.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.17% lower at present.
During the last 5 trading sessions, SRTS rose by +10.59%, which changed the moving average for the period of 200-days by +21.68% in comparison to the 20-day moving average, which settled at $3.37. In addition, Sensus Healthcare Inc saw 59.32% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SRTS starting from Sardano Joseph C, who purchase 10,000 shares at the price of $2.88 back on Sep 14 ’23. After this action, Sardano Joseph C now owns 1,175,293 shares of Sensus Healthcare Inc, valued at $28,773 using the latest closing price.
Sardano Michael, the PRESIDENT AND GENERAL COUNSEL of Sensus Healthcare Inc, purchase 1,000 shares at $2.99 during a trade that took place back on Aug 28 ’23, which means that Sardano Michael is holding 58,774 shares at $2,990 based on the most recent closing price.
Stock Fundamentals for SRTS
Current profitability levels for the company are sitting at:
- -0.02 for the present operating margin
- 0.58 for the gross margin
The net margin for Sensus Healthcare Inc stands at 0.02. The total capital return value is set at -0.01. Equity return is now at value 1.00, with 0.88 for asset returns.
Based on Sensus Healthcare Inc (SRTS), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -2.74. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 1.58.
Currently, EBITDA for the company is 30000.0 with net debt to EBITDA at 475.85. When we switch over and look at the enterprise to sales, we see a ratio of 1.61. The receivables turnover for the company is 2.29for trailing twelve months and the total asset turnover is 0.45. The liquidity ratio also appears to be rather interesting for investors as it stands at 11.76.
Conclusion
In conclusion, Sensus Healthcare Inc (SRTS) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
